Table 1

Baseline characteristics of patients contributing data to the IPD meta-analysis

CRASH-2WOMANCRASH-3HALT-ITAll
Randomised (N)20 21120 06012 73712 00965 017
Contributing IPD (N)20 12720 02112 63911 93764 724
Time to treatment (%)
 ≤313 485 (67)14 928 (75)9127 (72)1926 (16)39 466 (61)
 3–86613 (33)3637 (18)3474 (28)3136 (26)16 860 (26)
 >821 (0.1)1446 (7)38 (0.3)6874 (58)8379 (13)
 Missing8 (0)10 (0)0 (0)1 (0)19 (0)
 Mean (SD)2.8 (2.4)3.4 (23.4)2.9 (2.8)21.9 (36.8)6.5 (21.8)
 Median (IQR)2 (1-4)1.1 (.5–3.1)2.4 (1.6–3.5)11 (5–24)2.4 (1–5)
Age
 <202142 (11)1021 (5)956 (8)110 (1)4229 (7)
 20–3911 666 (58)18 312 (91)5266 (42)1455 (12)36 699 (57)
 40–594869 (24)681 (3)3399 (27)4664 (39)13 613 (21)
 60–791315 (7)0 (0)2279 (18)4184 (35)7778 (12)
 ≥80134 (1)0 (0)739 (6)1524 (13)2397 (4)
 Missing1 (0)7 (0)0 (0)0 (0)8 (0)
 Mean (SD)34.6 (14.3)28.3 (5.7)43.1 (19.8)58 (17)38.6 (17.7)
 Median (IQR)30 (24–43)28 (24–32)40 (25–58)58 (46–70)33 (25–50)
SBP
 <753042 (15)1606 (8)59 (0)327 (3)5034 (8)
 75–907004 (35)5853 (29)478 (4)2426 (20)15 761 (24)
 >9010 052 (50)12 557 (63)12 062 (95)9149 (77)43 820 (68)
 Missing29 (0)5 (0)40 (0)35 (0)109 (0)
 Mean (SD)97.0 (27.9)100.8 (22.7)130.6 (26.3)111.1 (23.6)107.4 (28.2)
 Median (IQR)91 (80–110)100 (90–110)129 (110–145)110 (95–125)100 (90–121)
  • IPD, individual patient data; SBP, systolic blood pressure.